LEIDOS BIOMEDICAL RESEARCH INC Federal Contracts — Government Award History
Total (All Time)$1.5B
Latest FY$932,383
Primary AgencyDepartment of Health and Human Services
LEIDOS BIOMEDICAL RESEARCH INC has received $1.5B in total federal contract awards
across 11 fiscal year(s). ▲ 7.2% vs FY2025 Peak year was FY2020 ($495M).
Primary awarding agency: Department of Health and Human Services.
Data covers largest contracts by award amount. Source: USASpending.gov (FPDS).
Awards by Fiscal Year
| Year | Spending | Total | Contracts | Top Agency |
|---|---|---|---|---|
| FY2026 | $932,383 | 6건 | Department of Health and Human Services | |
| FY2025 | $870,148 | 16건 | Department of Health and Human Services | |
| FY2024 | $1.3M | 15건 | Department of Health and Human Services | |
| FY2023 | $1.2M | 15건 | Department of Health and Human Services | |
| FY2022 | $2.0M | 23건 | Department of Health and Human Services | |
| FY2021 | $743,145 | 8건 | Department of Health and Human Services | |
| FY2020 | $494.6M | 21건 | Department of Health and Human Services | |
| FY2019 | $472.4M | 8건 | Department of Health and Human Services | |
| FY2018 | $343.0M | 22건 | Department of Health and Human Services | |
| FY2017 | $178.1M | 18건 | Department of Health and Human Services | |
| FY2016 | $37.2M | 11건 | Department of Health and Human Services |
Notable Contracts
| Date | Agency | Amount | Description |
|---|---|---|---|
| 2008-09-26 | Department of Health and Human Services | $20220.0M | TAS::75 0849::TAS OPER OF GOVT R&D GOCO FACILITIES |
| 2019-08-31 | Department of Health and Human Services | $437.4M | NCI OPERATIONAL TASK ORDER |
| 2020-09-02 | Department of Health and Human Services | $224.9M | NIAID COVID-19 ACTIV3 |
| 2020-04-01 | Department of Health and Human Services | $67.4M | ON BEHALF OF NIAID-DCR, FACILITATE THE CONDUCT OF TWO, RANDOMIZED TRIALS AS DETA |
| 2018-09-22 | Department of Health and Human Services | $58.1M | HHSN261201500003I; HHSN26100079; 400.001.0079.0001; NCI OD-FREDERICK; ROYALTY; B |
| 2020-06-30 | Department of Health and Human Services | $50.0M | COVID ACTIV3 TASK ORDER SUPPORTS NIAID’S GOAL TO BETTER UNDERSTAND THE CORONAVIR |
| 2018-09-11 | Department of Health and Human Services | $48.4M | HHSN261201500003I; HHSN26100071; 400.021.0071.0001; NCI CBIIT; APPROPRIATED; EXP |
| 2018-09-30 | Department of Health and Human Services | $43.3M | EBOLA VIRUS AND OTHER INFECTIOUS DISEASES |
| 2018-09-28 | Department of Health and Human Services | $41.2M | PDX PANELS FROM COMMON TUMORS |
| 2020-09-28 | Department of Health and Human Services | $41.0M | DEVELOPMENT OF TARGET CHARACTERIZATION METHODS FOR NOVEL CANCER MARKERS |
| 2017-09-21 | Department of Health and Human Services | $38.5M | IGF::OT::IGF A NATIONAL CLINICAL LABORATORY NETWORK FOR NCI PRECISION ONCOLOGY I |
| 2018-09-24 | Department of Health and Human Services | $33.3M | CELL-BASED IMMUNOTHERAPY PRODUCTS |
| 2017-09-28 | Department of Health and Human Services | $27.7M | IGF::OT::IGF BIOBANK |
| 2018-09-30 | Department of Health and Human Services | $27.1M | IGF::OT::IGF ADVANCE VACCINE PLATFORMS FOR UNIVERSAL INFLUENZA VACCINE |
| 2017-09-21 | Department of Health and Human Services | $25.3M | IGF::OT::IGF HIGH-PLEX PHARMACODYNAMIC BIOMARKER ASSAY |
| 2020-09-25 | Department of Health and Human Services | $22.0M | CHILDHOOD CANCER DATA INITIATIVE: CLINICAL TRIAL SPECIMEN MOLECULAR CHARACTERIZA |
| 2019-09-28 | Department of Health and Human Services | $21.7M | NCI FEDERALLY FUNDED RESEARCH AND DEVELOPMENT CENTER (FFRDC) CONTRACT – FY19 FAC |
| 2017-09-28 | Department of Health and Human Services | $21.3M | IGF::OT::IGF RETROSPECTIVE TUMOR CHARACTERIZATION ANALYSIS |
| 2018-09-28 | Department of Health and Human Services | $19.8M | RARE AND RECALCITRANT CANCERS FOR ESTABLISHING THE PREDICTIVE POWER OF PATIENT-D |
| 2017-09-21 | Department of Health and Human Services | $18.4M | IGF::OT::IGF CANINE IMMUNO-ONCOLOGY IGF::OT::IGF |